Intas Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat. The company is engaged in the development, manufacture and marketing of finished dosage formulations across several therapeutic areas, with a presence in both branded generics and biosimilars. Intas operates through subsidiaries and affiliates in multiple international markets, including Europe, North America and emerging economies.
| Name | Intas Pharmaceuticals Limited |
|---|---|
| Type | Private company |
| Industry | Pharmaceuticals, biotechnology |
| Headquarters | Ahmedabad, Gujarat, India |
| Country | India |
| Area served | Worldwide |
| Products | Generic medicines, biosimilars, formulations |
Overview
Intas operates as a vertically integrated pharmaceutical company, with capabilities spanning research and development, active pharmaceutical ingredient (API) manufacturing, formulation development, and commercial sales. Its therapeutic focus areas include oncology, neurology, cardiovascular, diabetology, gastroenterology, gynaecology, and biotechnology-derived products.
Background
The company is privately held and is part of a wider group structure that includes affiliated businesses in animal health and biopharmaceuticals. Intas markets a number of branded generic products in the Indian domestic pharmaceutical market and exports formulations to regulated and semi-regulated markets globally.
International operations
Intas has built an international presence largely through its subsidiary Accord Healthcare, which markets generic medicines in Europe, the United Kingdom, North America and other regions. Accord Healthcare functions as the principal vehicle for the company's regulated-market business and has expanded through both organic growth and acquisitions of regional generic businesses.
Biosimilars and biotechnology
The company maintains a biopharmaceutical division focused on the development and manufacture of biosimilar products, particularly in oncology and supportive care. This includes biologic therapeutics produced through recombinant technology platforms.
Manufacturing and research
Intas operates manufacturing facilities in Gujarat and other locations in India, producing solid orals, injectables, biologics and other dosage forms. Several of its plants are designed to meet the standards of major regulatory authorities, including the United States Food and Drug Administration (USFDA), the European Medicines Agency (EMA), and the Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom. The company also operates dedicated research and development centres for formulation development, analytical research and biotechnology.
Significance
Intas is considered one of the larger Indian pharmaceutical companies by revenue and is a notable participant in the Indian generics export industry. Its biosimilars portfolio and Accord Healthcare's European footprint have positioned it among the prominent Indian-origin firms supplying generic and biosimilar medicines to regulated markets.
Related topics
- Pharmaceutical industry in India
- Accord Healthcare
- Biosimilar
- Ahmedabad
- List of pharmaceutical companies in India
- Generic drug
References
- Wikidata entry: Q108782794